UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Implementation of foetal fibronectin testing: Admissions, maternal interventions and costs at 1 year

Parisaei, M; Currie, J; O'Gorman, N; Morris, S; David, AL; (2016) Implementation of foetal fibronectin testing: Admissions, maternal interventions and costs at 1 year. Journal of Obstetrics and Gynaecology , 36 (7) pp. 888-892. 10.3109/01443615.2016.1168374. Green open access

[img]
Preview
Text
Parisaei_Implementation_foetal_fibronectin_testing_No-markup.pdf

Download (245kB) | Preview

Abstract

Foetal fibronectin testing (fFN) has a high negative predictive value for preterm delivery, but it has a cost implication. This two-stage prospective study evaluated the real patient costs and clinical impact of introducing the fFN test in women presenting acutely with threatened preterm labour in a tertiary UK obstetric hospital. Introduction of the fFN test for women with threatened preterm labour reduced antenatal admissions and in utero transfers, and reduced steroid treatment and tocolysis, even at 1 year after implementation. The total number of bed days for women with threatened preterm labour who did not deliver during admission fell from 132 (mean 8.8 days) to 25 days (mean 3.6 days). The mean cost of admission per woman before introduction of the fFN test was £1032 (95% CI £880 to £1184); after it was £339 (95% CI £261 to £417). In this small single centre study, the introduction of the test produced a cost saving of £693 per woman (95% CI, £464 to £922) which over 12 months potentially saves £74844 (95% CI £50,112 to £99,576). Further studies are needed to formally evaluate the cost-effectiveness of the fFN test and its impact on clinical decision-making in large populations.

Type: Article
Title: Implementation of foetal fibronectin testing: Admissions, maternal interventions and costs at 1 year
Open access status: An open access version is available from UCL Discovery
DOI: 10.3109/01443615.2016.1168374
Publisher version: http://dx.doi.org/10.3109/01443615.2016.1168374
Language: English
Additional information: Copyright © 2016 Informa UK Limited, trading as Taylor & Francis Group. This is an Accepted Manuscript of an article published by Taylor & Francis in Journal of Obstetrics and Gynaecology on 5 May 2016, available online: http://www.tandfonline.com/10.3109/01443615.2016.1168374
Keywords: Foetal fibronectin test, cost effectiveness, spontaneous preterm birth, threatened preterm labour
UCL classification: UCL
UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health > Applied Health Research
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health > Maternal and Fetal Medicine
URI: https://discovery.ucl.ac.uk/id/eprint/1494604
Downloads since deposit
141Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item